News & Insight

News
A network approach reveals roles for cancer stem cells in cancer promotion
Q&A with Professor Allan Balmain and Dr Mark Taylor on new findings from the PROMINENT team, tackling our Normal Phenotypes challenge
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell carcinoma development…

Latest

News
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the…
News
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over…
Blog
As we look towards announcing our new teams on 6 March, we reflect with former members of the Cancer Grand Challenges Advocacy Panel on the role the…
Blog
Last month we held our annual Future Leaders Conference in Lisbon. As well as being a time for early career researchers from across our funded teams…

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Video
Nearly 170 diverse, global teams submitted bold ideas outlining how they would solve some of cancer’s toughest challenges. Today, we reveal the 11 teams selected to compete for a share of £80m.   We were delighted to…
News
APC is one of the most commonly mutated genes in colorectal tumours – but why is it so frequently mutated in this type of cancer compared to others? The answer lies in the way APC-mutant cells compete with their…
Video
Patient advocate Helen Matthews meets co-investigator Owen Sansom to discuss SPECIFICANCER’s latest findings, how working cross-discipline enables ‘big strides forward’ and the unique, important perspectives brought to…
News
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.   OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and…
News
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand Challenges PRECISION team could spare thousands of women around the…
Video
Look inside the IMAXT team’s virtual reality lab, ahead of its release later this year, as the team calls for volunteers to help test the software.  A core component of the Cancer Grand Challenges IMAXT programme,…
News
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the disease. Colorectal cancer is the third most common cancer in the world…
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our blog series, members of our Cancer Grand Challenges Scientific Committee…
Video
We recently held a webinar with the American Association for Cancer Research (AACR) providing an overview of the Cancer Grand Challenges partnership between Cancer Research UK and the US National Cancer Institute. …